Injective Price History (INJ)
Current price: $4.81 · 5-year history · Updated: 7/31/2026
Not financial advice. Read disclaimer
Price Chart (5 Years)
Year-by-Year Performance
| Year | Open | Close | High | Low | Year ROI |
|---|---|---|---|---|---|
| 2026 | $3.11 | $4.74 | $7.03 | $2.74 | +52.41% |
Year-by-Year Analysis
Injective in 2026
2026 was a year of strong rally for Injective. Price opened at $3.11 and closed at $4.74 — an annual return of +52.41%. Within the year, prices ranged between $2.74 and $7.03 — a 157% range.
Injective in Market Context
Market Position
Injective (INJ) currently sits in the long-tail without a stable top-100 rank — higher upside but materially elevated risk, with a current market cap of $480.89 M. Injective falls into a specialized category with valuation drivers that differ from mainstream L1s and DeFi tokens.
Recent Price Action
At $4.81 (only 9% of the ATH of $52.62), Injective is in a deep correction — drawdowns of this magnitude have historically offered attractive re-entry zones depending on fundamentals. Over the last 7 days, Injective has dropped −7.9%; over 30 days it has moved sideways at +0.30%.
Valuation Signals
A Value Score of 70.7/100 places Injective in the "Undervalued" zone, indicating a discount versus realized market cap and network activity. MVRV at 95/100 suggests a favorable valuation relative to realized cap. Low dev activity (score 30/100) is a cluster risk — project stagnation elevates long-term delisting risk. The NVT ratio (90/100) shows healthy network activity relative to market cap.
Risk Profile
Specialized tokens carry use-case concentration risk: if the core thesis fails, pivoting is rarely viable. Strong tokenomics (85/100): bounded emission, decentralized distribution, and no activation cliffs on the horizon. Outside the top 100, exchange liquidity is thin and slippage on larger trades is non-trivial.
Cycle Insights
- Biggest rally: From ATL ($2.74) to ATH ($7.03), Injective gained 157% — typical for bull market tops.
- Current state: Injective currently trades at 68.4% of its ATH and 76% above its ATL.
- Volatility: Price range between ATH and ATL is 2.6x — crypto-typical high volatility that makes DCA strategies (vs lump-sum) attractive.
Frequently Asked Questions
What is the Injective all-time high?
Injective's all-time high in our historical data is $7.03 on 6/1/2026. Currently Injective trades at $4.81 — below the ATH (68.4% of peak). Data covers the past 5 years.
What is the Injective all-time low?
Injective's lowest price in the past 5 years was $2.74 on 4/2/2026. From ATL to today, the price moved 76%.
How has Injective performed in recent years?
Annual returns: 2026: +52.41%. Across all 1 years in our data: +54.66% total return from first data point.
Where does the historical price data come from?
All price data is sourced from CoinGecko — one of the largest and most reputable crypto data providers. We store daily closing prices for the past 5 years. Data refreshes daily (24h ISR cache).